Bridgeway Capital Management’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$15K Sell
2022
Q2
$25K Sell
2022
Q1
$54K Sell
2021
Q4
$284K Sell
2021
Q3
$808K Buy
2021
Q2
$340K Sell
2021
Q1
$1.33M Buy
2020
Q4
$644K Hold
2020
Q3
$766K Sell
2020
Q2
$1.09M Buy
2020
Q1
$68K Buy